Şahin, Tuğçe Demirtaş <br/><br/>
Infliximab prevents dysfunction of the vas deferens by suppressing inflammation and oxidative stress in rats with chronic stress.  [electronic resource] 

 -  Life sciences  Jun 2020 
 - 117545 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2020.117545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Antioxidants--metabolism<br/>Biomarkers--metabolism<br/>Corticosterone--blood<br/>Depression--drug therapy<br/>Dose-Response Relationship, Drug<br/>Ejaculation--drug effects<br/>Electromagnetic Fields<br/>Glutathione--metabolism<br/>Inflammation--blood<br/>Infliximab--pharmacology<br/>Lipid Peroxidation<br/>Male<br/>Norepinephrine--metabolism<br/>Oxidative Stress<br/>Rats<br/>Rats, Wistar<br/>Stress, Physiological<br/>Sucrose--chemistry<br/>Superoxide Dismutase--metabolism<br/>Vas Deferens--drug effects